Dan Haupt

1.7k total citations
34 papers, 1.3k citations indexed

About

Dan Haupt is a scholar working on Psychiatry and Mental health, Automotive Engineering and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Dan Haupt has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 9 papers in Automotive Engineering and 8 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Dan Haupt's work include Schizophrenia research and treatment (10 papers), Vehicle emissions and performance (9 papers) and Diet and metabolism studies (6 papers). Dan Haupt is often cited by papers focused on Schizophrenia research and treatment (10 papers), Vehicle emissions and performance (9 papers) and Diet and metabolism studies (6 papers). Dan Haupt collaborates with scholars based in United States and Sweden. Dan Haupt's co-authors include John W. Newcomer, Julia Schweiger, Angela K. Melson, Benjamin P. Cooper, Robert Fucetola, Gregg Selke, Ross A. Baker, Richard Whitehead, Lisa Rosenblatt and J. Lars G. Nilsson and has published in prestigious journals such as Environmental Science & Technology, American Journal of Psychiatry and Neuropsychopharmacology.

In The Last Decade

Dan Haupt

34 papers receiving 1.2k citations

Peers

Dan Haupt

PMH

EDM

PHYSI

PHARM

FFTP

Claudia Asenjo‐Lobos Chile

Anna Marseglia Sweden

Pedro Velasquez‐Mieyer United States

Jeanmarie R. Burke United States

James C. Baldi New Zealand

Jesper Fleischer Denmark

Monique E. François Australia

Giovanni Mazzotta Italy

D. Gustafson United States

Bo Palmertz Sweden

Claudia Asenjo‐Lobos Chile

Dan Haupt

820 ×1.0

PMH

165 ×0.4

EDM

181 ×0.5

PHYSI

147 ×1.5

PHARM

0 ×0.0

FFTP

Citations per year, relative to Dan Haupt Dan Haupt (= 1×) peers Claudia Asenjo‐Lobos

Countries citing papers authored by Dan Haupt

Since Specialization

Citations

This map shows the geographic impact of Dan Haupt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dan Haupt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dan Haupt more than expected).

Fields of papers citing papers by Dan Haupt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dan Haupt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dan Haupt. The network helps show where Dan Haupt may publish in the future.

Co-authorship network of co-authors of Dan Haupt

This figure shows the co-authorship network connecting the top 25 collaborators of Dan Haupt. A scholar is included among the top collaborators of Dan Haupt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dan Haupt. Dan Haupt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nilsson, J. Lars G., et al.. (2009). Asthma/COPD drugs reflecting disease prevalence, patient adherence and persistence. Expert Review of Respiratory Medicine. 3(1). 93–101. 3 indexed citations

Haupt, Dan, Lisa Rosenblatt, Edward Kim, et al.. (2009). Prevalence and Predictors of Lipid and Glucose Monitoring in Commercially Insured Patients Treated With Second-Generation Antipsychotic Agents. American Journal of Psychiatry. 166(3). 345–353. 149 indexed citations

Haupt, Dan & J. Lars G. Nilsson. (2009). Asthma medication - persistence with adrenergics, steroids and combination products over a 5-year period. Journal of Clinical Pharmacy and Therapeutics. 34(5). 507–513. 9 indexed citations

Haupt, Dan, Björn Wettermark, & J. Lars G. Nilsson. (2008). Dispensed volumes of anti‐asthmatic drugs related to the prevalence of asthma and COPD in Sweden. Pharmacoepidemiology and Drug Safety. 17(5). 461–467. 4 indexed citations

Haupt, Dan, Gunilla Ringbäck Weitoft, & J. Lars G. Nilsson. (2008). Refill adherence to oral antihyperglycaemic drugs in Sweden. Acta Diabetologica. 46(3). 203–208. 15 indexed citations

Haupt, Dan, et al.. (2008). Medication persistence among patients with asthma/COPD drugs. Pharmacy World & Science. 30(5). 509–514. 41 indexed citations

Haupt, Dan, et al.. (2007). Adiposity and Insulin Sensitivity Derived from Intravenous Glucose Tolerance Tests in Antipsychotic-Treated Patients. Neuropsychopharmacology. 32(12). 2561–2569. 36 indexed citations

Haupt, Dan & John M. Kane. (2007). Metabolic Risks and Effects of Atypical Antipsychotic Treatment. The Journal of Clinical Psychiatry. 68(10). e24–e24. 6 indexed citations

Haupt, Dan. (2007). Impact of Medical Comorbidity on Medication Management of Schizophrenia. CNS Spectrums. 12(S21). 15–17. 2 indexed citations

10.

Haupt, Dan. (2006). Differential metabolic effects of antipsychotic treatments. European Neuropsychopharmacology. 16. S149–S155. 101 indexed citations

11.

Ketter, Terence A. & Dan Haupt. (2006). Perceptions of weight gain and bipolar pharmacotherapy: results of a 2005 survey of physicians in clinical practice. Current Medical Research and Opinion. 22(12). 2345–2353. 34 indexed citations

12.

Haupt, Dan, et al.. (2005). Reducing the Emission of Particles from a Diesel Engine by Adding an Oxygenate to the Fuel. Environmental Science & Technology. 39(16). 6260–6265. 39 indexed citations

13.

Casey, Daniel E., Dan Haupt, John W. Newcomer, et al.. (2004). Schizophrenia, Metabolic Disorders, and Cardiovascular Disease. The Journal of Clinical Psychiatry. 65. 8–8. 2 indexed citations

14.

Haupt, Dan, et al.. (2004). Plasma Leptin and Adiposity During Antipsychotic Treatment of Schizophrenia. Neuropsychopharmacology. 30(1). 184–191. 54 indexed citations

15.

Newcomer, John W., et al.. (2003). Fasting plasma lipids, glucose and insulin, and C-reactive protein are related to adiposity in schizophrenia. Schizophrenia Research. 60(1). 363–363. 1 indexed citations

16.

Fucetola, Robert, Dan Haupt, Benjamin P. Cooper, et al.. (2002). Insulin resistance measured with euglycemic clamps during antipsychotic treatment of schizophrenia. 89514. 5 indexed citations

17.

Newcomer, John W., Dan Haupt, Robert Fucetola, et al.. (2002). Abnormalities in Glucose Regulation During Antipsychotic Treatment of Schizophrenia. Archives of General Psychiatry. 59(4). 337–337. 412 indexed citations

18.

Haupt, Dan, et al.. (2002). Evaluating a Fischer-Tropsch Fuel, Eco-Par™, in a Valmet Diesel Engine. SAE technical papers on CD-ROM/SAE technical paper series. 1. 12 indexed citations

19.

Haupt, Dan, et al.. (2001). Characterization of components classified as hydrocarbons when using a heated flame ionization detector for measuremetns of exhaust gases form an 11 litres ethanol fueled engine. 1 indexed citations

20.

Halperin, Blair D., et al.. (1994). Early Changes in Defibrillation Threshold Following Implantation of a Nonthoracotomy System in Dogs. Pacing and Clinical Electrophysiology. 17(11). 1771–1777. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact